111 related articles for article (PubMed ID: 7746351)
1. Neurochemical and behavioural effects of neurotensin vs [D-Tyr11]neurotensin on mesolimbic dopaminergic function.
Steinberg R; Brun P; Souilhac J; Bougault I; Leyris R; Le Fur G; Soubrié P
Neuropeptides; 1995 Jan; 28(1):43-50. PubMed ID: 7746351
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of neurotensin, neurotensin(8-13) and [D-Tyr(11)]neurotensin applied into the ventral tegmental area on extracellular dopamine in the rat prefrontal cortex and nucleus accumbens.
Sotty F; Brun P; Leonetti M; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
Neuroscience; 2000; 98(3):485-92. PubMed ID: 10869842
[TBL] [Abstract][Full Text] [Related]
3. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: a combined in vivo electrochemical and electrophysiological study.
Sotty F; Soulière F; Brun P; Chouvet G; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
Neuroscience; 1998 Aug; 85(4):1173-82. PubMed ID: 9681955
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin receptor 1-biased ligand attenuates neurotensin-mediated excitation of ventral tegmental area dopamine neurons and dopamine release in the nucleus accumbens.
Singhal SM; Zell V; Faget L; Slosky LM; Barak LS; Caron MG; Pinkerton AB; Hnasko TS
Neuropharmacology; 2023 Aug; 234():109544. PubMed ID: 37055008
[TBL] [Abstract][Full Text] [Related]
6. Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission.
Yan QS; Zheng SZ; Feng MJ; Yan SE
Brain Res; 2005 Oct; 1060(1-2):126-37. PubMed ID: 16212943
[TBL] [Abstract][Full Text] [Related]
7. SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.
Steinberg R; Brun P; Fournier M; Souilhac J; Rodier D; Mons G; Terranova JP; Le Fur G; Soubrié P
Neuroscience; 1994 Apr; 59(4):921-9. PubMed ID: 8058127
[TBL] [Abstract][Full Text] [Related]
8. Specific involvement of neurotensin type 1 receptor in the neurotensin-mediated in vivo dopamine efflux using knock-out mice.
Leonetti M; Brun P; Clerget M; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
J Neurochem; 2004 Apr; 89(1):1-6. PubMed ID: 15030383
[TBL] [Abstract][Full Text] [Related]
9. Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
Brun P; Leonetti M; Sotty F; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
J Neurochem; 2001 Jun; 77(6):1542-52. PubMed ID: 11413237
[TBL] [Abstract][Full Text] [Related]
10. Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens.
Brun P; Steinberg R; Le Fur G; Soubrié P
J Neurochem; 1995 May; 64(5):2073-9. PubMed ID: 7722490
[TBL] [Abstract][Full Text] [Related]
11. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.
Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
Neuropharmacology; 1999 Aug; 38(8):1195-205. PubMed ID: 10462132
[TBL] [Abstract][Full Text] [Related]
12. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
Ford AP; Marsden CA
Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
[TBL] [Abstract][Full Text] [Related]
13. Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study.
Yan QS; Yan SE
Eur J Pharmacol; 2001 Apr; 418(1-2):55-64. PubMed ID: 11334865
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats.
Melis MR; Melis T; Cocco C; Succu S; Sanna F; Pillolla G; Boi A; Ferri GL; Argiolas A
Eur J Neurosci; 2007 Aug; 26(4):1026-35. PubMed ID: 17672853
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens.
Laitinen K; Crawley JN; Mefford IN; De Witte P
Brain Res; 1990 Jul; 523(2):342-6. PubMed ID: 1698106
[TBL] [Abstract][Full Text] [Related]
16. The modulatory effect of neurotensin on [3H]dopamine release from rat nucleus accumbens slices is enhanced after chronic desipramine treatment.
Reyneke L; Russell VA; Taljaard JJ
Brain Res; 1987 Nov; 425(1):114-9. PubMed ID: 3427414
[TBL] [Abstract][Full Text] [Related]
17. The effects of neurotensin and [D-Tyr11]-NT on the hyperactivity induced by intra-accumbens administration of a potent dopamine receptor agonist.
Jolicoeur FB; Rivest R; St-Pierre S; Gagné MA; Dumais M
Neuropeptides; 1985 Apr; 6(2):143-56. PubMed ID: 2987745
[TBL] [Abstract][Full Text] [Related]
18. Extracellular dopamine in the anterior nucleus accumbens is distinctly affected by ventral tegmental area administration of cholecystokinin and apomorphine: data from in vivo voltammetry.
Reum T; Fink H; Marsden CA; Morgenstern R
Neuropeptides; 1998 Apr; 32(2):161-6. PubMed ID: 9639255
[TBL] [Abstract][Full Text] [Related]
19. Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections.
Ferrari R; Le Novère N; Picciotto MR; Changeux JP; Zoli M
Eur J Neurosci; 2002 Jun; 15(11):1810-8. PubMed ID: 12081661
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens.
Schilström B; Nomikos GG; Nisell M; Hertel P; Svensson TH
Neuroscience; 1998 Feb; 82(3):781-9. PubMed ID: 9483535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
